Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elke Schaeffeler

Showing results (1-10 of 189) with videos related to

Pageof 19
Sort By:
Blood|September 17, 2011
Warfarin pharmacogenetics meets clinical useMatthias Schwab, Elke Schaeffeler
Genome Medicine|December 1, 2012
Pharmacogenomics: a key component of personalized therapyMatthias Schwab, Elke Schaeffeler
Signal Transduction and Targeted Therapy|April 8, 2025
Personalized cancer vaccination is emerging: lessons learnt from renal cancer and challenges for broader applicationElke Schaeffeler, Juliane Walz, Matthias Schwab
Clinical and Translational Science|April 17, 2018
Clinical and Functional Relevance of the Monocarboxylate Transporter Family in Disease Pathophysiology and Drug TherapyPascale Fisel, Elke Schaeffeler, Matthias Schwab
Pharmacology & Therapeutics|August 22, 2022
Hepatic solute carrier transporters and drug therapy: Regulation of expression and impact of genetic variationAnne T Nies, Elke Schaeffeler, Matthias Schwab
British Journal of Clinical Pharmacology|July 30, 2014
Mechanisms and assessment of statin-related muscular adverse effectsDirk Moßhammer, Elke Schaeffeler, Matthias Schwab, et al.
Clinical Pharmacology and Therapeutics|September 17, 2004
CYP2C19 polymorphism is a major predictor of treatment failure in white patients by use of lansoprazole-based quadruple therapy for eradication of Helicobacter pyloriMatthias Schwab, Elke Schaeffeler, Ulrich Klotz, et al.
Expert Opinion on Drug Metabolism & Toxicology|February 1, 2017
The importance of drug transporter characterization to precision medicinePascale Fisel, Anne T Nies, Elke Schaeffeler, et al.
Expert Opinion on Drug Metabolism & Toxicology|September 14, 2012
Multidrug and toxin extrusion proteins as transporters of antimicrobial drugsAnne T Nies, Katja Damme, Elke Schaeffeler, et al.
European Urology|May 18, 2023
Re: Judikael R. Saout, Gwendoline Lecuyer, Simon Léonard, et al. Single-cell Deconvolution of a Specific Malignant Cell Population as a Poor Prognostic Biomarker in Low-risk Clear Cell Renal Cell Carcinoma Patients. Eur Urol. 2023;83:441-51Anna Reustle, Florian A Büttner, Matthias Schwab, et al.
Pageof 19

Showing results (1-10 of 189) with videos related to

Sort By:
Pageof 19
Blood|September 17, 2011
Warfarin pharmacogenetics meets clinical useMatthias Schwab, Elke Schaeffeler
Genome Medicine|December 1, 2012
Pharmacogenomics: a key component of personalized therapyMatthias Schwab, Elke Schaeffeler
Signal Transduction and Targeted Therapy|April 8, 2025
Personalized cancer vaccination is emerging: lessons learnt from renal cancer and challenges for broader applicationElke Schaeffeler, Juliane Walz, Matthias Schwab
Clinical and Translational Science|April 17, 2018
Clinical and Functional Relevance of the Monocarboxylate Transporter Family in Disease Pathophysiology and Drug TherapyPascale Fisel, Elke Schaeffeler, Matthias Schwab
Pharmacology & Therapeutics|August 22, 2022
Hepatic solute carrier transporters and drug therapy: Regulation of expression and impact of genetic variationAnne T Nies, Elke Schaeffeler, Matthias Schwab
British Journal of Clinical Pharmacology|July 30, 2014
Mechanisms and assessment of statin-related muscular adverse effectsDirk Moßhammer, Elke Schaeffeler, Matthias Schwab, et al.
Clinical Pharmacology and Therapeutics|September 17, 2004
CYP2C19 polymorphism is a major predictor of treatment failure in white patients by use of lansoprazole-based quadruple therapy for eradication of Helicobacter pyloriMatthias Schwab, Elke Schaeffeler, Ulrich Klotz, et al.
Expert Opinion on Drug Metabolism & Toxicology|February 1, 2017
The importance of drug transporter characterization to precision medicinePascale Fisel, Anne T Nies, Elke Schaeffeler, et al.
Expert Opinion on Drug Metabolism & Toxicology|September 14, 2012
Multidrug and toxin extrusion proteins as transporters of antimicrobial drugsAnne T Nies, Katja Damme, Elke Schaeffeler, et al.
European Urology|May 18, 2023
Re: Judikael R. Saout, Gwendoline Lecuyer, Simon Léonard, et al. Single-cell Deconvolution of a Specific Malignant Cell Population as a Poor Prognostic Biomarker in Low-risk Clear Cell Renal Cell Carcinoma Patients. Eur Urol. 2023;83:441-51Anna Reustle, Florian A Büttner, Matthias Schwab, et al.
Pageof 19